--- title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/281184980.md" description: "In Tuesday's pre-market session, Apellis Pharmaceuticals saw a significant gain of 138.8%, reaching $40.81, with a market cap of $2.1 billion. Other notable gainers included Virax Biolabs (up 62.43%), Centessa Pharmaceuticals (up 47.49%), and Insight Molecular (up 34.9%). Conversely, PepGen experienced a sharp decline of 48.7%, followed by Iterum Therapeutics (down 32.53%) and Phreesia (down 24.19%). Several companies reported Q4 earnings recently, impacting stock movements." datetime: "2026-03-31T12:05:43.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281184980.md) - [en](https://longbridge.com/en/news/281184980.md) - [zh-HK](https://longbridge.com/zh-HK/news/281184980.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/281184980.md) | [English](https://longbridge.com/en/news/281184980.md) # 12 Health Care Stocks Moving In Tuesday's Pre-Market Session ### Gainers - **Apellis Pharmaceuticals** (NASDAQ:APLS) shares moved upwards by 138.8% to $40.81 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. - **Virax Biolabs Group** (NASDAQ:VRAX) shares rose 62.43% to $0.26. The market value of their outstanding shares is at $1.2 million. - **Centessa Pharmaceuticals** (NASDAQ:CNTA) stock rose 47.49% to $40.68. The market value of their outstanding shares is at $4.0 billion. - **Insight Molecular** (NASDAQ:IMDX) stock rose 34.9% to $3.44. The company's market cap stands at $82.0 million. The company's, Q4 earnings came out 3 days ago. - **IM Cannabis** (NASDAQ:IMCC) stock increased by 30.19% to $0.53. The market value of their outstanding shares is at $2.4 million. - **Lantern Pharma** (NASDAQ:LTRN) stock rose 19.83% to $1.48. The company's market cap stands at $13.8 million. The company's, Q4 earnings came out yesterday. ### Losers - **PepGen** (NASDAQ:PEPG) shares fell 48.7% to $2.17 during Tuesday's pre-market session. The company's market cap stands at $290.8 million. - **Iterum Therapeutics** (NASDAQ:ITRM) stock declined by 32.53% to $0.05. The company's market cap stands at $3.7 million. - **Phreesia** (NYSE:PHR) stock fell 24.19% to $8.65. The company's market cap stands at $687.8 million. As per the news, the Q4 earnings report came out yesterday. - **Sangamo Therapeutics** (NASDAQ:SGMO) stock fell 16.73% to $0.26. The market value of their outstanding shares is at $114.2 million. As per the news, the Q4 earnings report came out yesterday. - **BioLife Solutions** (NASDAQ:BLFS) stock fell 15.87% to $15.8. The company's market cap stands at $899.6 million. - **ImageneBio** (NASDAQ:IMA) stock decreased by 14.0% to $4.3. The market value of their outstanding shares is at $55.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### 相關股票 - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md) - [PepGen (PEPG.US)](https://longbridge.com/zh-HK/quote/PEPG.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [Insight Molecular Diagnostics (IMDX.US)](https://longbridge.com/zh-HK/quote/IMDX.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md) - [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md) - [Phreesia (PHR.US)](https://longbridge.com/zh-HK/quote/PHR.US.md) - [Apellis Pharma (APLS.US)](https://longbridge.com/zh-HK/quote/APLS.US.md) - [Virax Biolabs (VRAX.US)](https://longbridge.com/zh-HK/quote/VRAX.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [Centessa Pharmaceuticals (CNTA.US)](https://longbridge.com/zh-HK/quote/CNTA.US.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md) - [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md) - [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md) - [Iterum Therap (ITRM.US)](https://longbridge.com/zh-HK/quote/ITRM.US.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [ITERUM THERAPEUTICS PLC (ITRMF.US)](https://longbridge.com/zh-HK/quote/ITRMF.US.md) ## 相關資訊與研究 - [Iterum Therapeutics Files Wind Up Petition; Shares Shoot In Pre-market](https://longbridge.com/zh-HK/news/280999380.md) - [Iterum Therapeutics Received Notice of Delisting](https://longbridge.com/zh-HK/news/281174211.md) - [EXCLUSIVE: Penny Stock Scienture Reports Revenue Surge, Expanding Market Access In 2025](https://longbridge.com/zh-HK/news/281015927.md) - [PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway](https://longbridge.com/zh-HK/news/281268875.md) - [21:44 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG](https://longbridge.com/zh-HK/news/281592796.md)